Showing 19,821 - 19,840 results of 101,733 for search '(( 5 point decrease ) OR ( 5 ((fold decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.89s Refine Results
  1. 19821

    S1 Dataset - by Ferenc Tóth (665272)

    Published 2024
    “…During the same period, lesion size decreased by an average of 7.6 mm<sup>2</sup> (95% CI: [-24.5, 19.4]; p = 0.83) in piglets receiving partial devascularization. …”
  2. 19822

    MRI scan parameters for one stifle. by Ferenc Tóth (665272)

    Published 2024
    “…During the same period, lesion size decreased by an average of 7.6 mm<sup>2</sup> (95% CI: [-24.5, 19.4]; p = 0.83) in piglets receiving partial devascularization. …”
  3. 19823
  4. 19824
  5. 19825
  6. 19826

    Table_2_Oral Zinc Sulfate for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis: A Meta-Analysis of Five Randomized Controlled Trials.DOC by Xu Tian (179192)

    Published 2018
    “…We included five eligible studies involving 352 patients. Meta-analysis based on limited data revealed that oral zinc sulfate failed to decrease the incidence of chemotherapy-induced oral mucositis (RR [relative risk] = 0.52, 95% CI [confidence interval] = 0.17–1.64) as well as relieve chemotherapy-induced oral mucositits grade (RR = 0.62, 95% CI = 0.11–3.56; RR = 0.70, 95% CI = 0.29–1.71). …”
  7. 19827

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  8. 19828

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  9. 19829
  10. 19830

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  11. 19831

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  12. 19832

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  13. 19833

    Table_1_Oral Zinc Sulfate for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis: A Meta-Analysis of Five Randomized Controlled Trials.DOCX by Xu Tian (179192)

    Published 2018
    “…We included five eligible studies involving 352 patients. Meta-analysis based on limited data revealed that oral zinc sulfate failed to decrease the incidence of chemotherapy-induced oral mucositis (RR [relative risk] = 0.52, 95% CI [confidence interval] = 0.17–1.64) as well as relieve chemotherapy-induced oral mucositits grade (RR = 0.62, 95% CI = 0.11–3.56; RR = 0.70, 95% CI = 0.29–1.71). …”
  14. 19834

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  15. 19835
  16. 19836

    Individual (in grey) and overall (in black) median adjustment errors at the beginning (left column) and at the end (right column) of each five-minute run derived from the fitted tr... by Alexander A. Tarnutzer (299365)

    Published 2013
    “…While panels A and C show all traces with significantly increasing errors over time, panels B and D illustrate traces that had a significant decrease in error.…”
  17. 19837

    Flowchart of the study population. by Alejandro Rojas Chaves (20614814)

    Published 2025
    “…This study examines the relationship between asymptomatic malaria infection and hemoglobin levels in Benin.</p><p>Methods</p><p>A cohort in Benin was enrolled and categorized into three age groups (under 5 years, 5–15 years, and over 15 years) for follow-up from August to November 2021. …”
  18. 19838

    Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5‑LOX Inhibitor that Limits Inflammation by Konstantin Neukirch (11153961)

    Published 2021
    “…Endogenous long-chain metabolites of vitamin E (LCMs) mediate immune functions by targeting 5-lipoxygenase (5-LOX) and increasing the systemic concentrations of resolvin E3, a specialized proresolving lipid mediator. …”
  19. 19839
  20. 19840